LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 33.80 | 21.74 | 2095 | 2381 | 0.8797 | 0.9625 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 35.77 | 21.74 | 1363 | 2602 | 0.5237 | 0.8211 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 35.77 | 21.74 | 1885 | 2602 | 0.7242 | 0.9087 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 35.77 | 21.74 | 1992 | 2602 | 0.7653 | 0.9240 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 35.77 | 21.74 | 2015 | 2602 | 0.7742 | 0.9272 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 35.77 | 21.74 | 60 | 2602 | 0.0231 | 0.1584 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 35.77 | 21.74 | 2294 | 2602 | 0.8813 | 0.9637 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 37.74 | 21.74 | 1530 | 2828 | 0.5409 | 0.8325 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 37.74 | 21.74 | 1931 | 2828 | 0.6827 | 0.8942 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 37.74 | 21.74 | 2133 | 2828 | 0.7541 | 0.9212 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 37.74 | 21.74 | 2156 | 2828 | 0.7623 | 0.9242 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 37.74 | 21.74 | 87 | 2828 | 0.0308 | 0.2183 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 37.74 | 21.74 | 2364 | 2828 | 0.8358 | 0.9496 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 39.71 | 21.74 | 1806 | 3084 | 0.5856 | 0.8557 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 39.71 | 21.74 | 2137 | 3084 | 0.6929 | 0.9000 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 39.71 | 21.74 | 2243 | 3084 | 0.7273 | 0.9129 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 39.71 | 21.74 | 2262 | 3084 | 0.7334 | 0.9151 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 39.71 | 21.74 | 108 | 3084 | 0.0350 | 0.2514 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 39.71 | 21.74 | 2574 | 3084 | 0.8346 | 0.9501 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 41.68 | 21.74 | 2073 | 3418 | 0.6064 | 0.8675 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 41.68 | 21.74 | 2317 | 3418 | 0.6777 | 0.8962 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 41.68 | 21.74 | 2380 | 3418 | 0.6962 | 0.9032 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 41.68 | 21.74 | 2395 | 3418 | 0.7005 | 0.9048 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 41.68 | 21.74 | 107 | 3418 | 0.0313 | 0.2441 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 41.68 | 21.74 | 2701 | 3418 | 0.7901 | 0.9364 | MN20160310_N01 | I21 |